Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-06-09 9:15 pm | N/A N/A | Parabilis Medicines Inc. | PBLS | Flynn James E Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,880,704 (Indirect) | View |
| 2026-05-19 Option Award | 2026-05-20 8:02 pm | N/A 2036-05-19 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. * Director by Deputization Director 10% Owner | 55,150 | $0 | 55,150 (Indirect) | View |
| 2025-06-18 Option Award | 2025-06-20 9:08 pm | N/A 2035-06-18 | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 10,941 | $0 | 18,006,963 (Indirect) | View |
| 2025-05-13 Option Award | 2025-05-15 7:44 pm | N/A 2035-05-13 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 19,000 | $0 | 19,000 (Indirect) | View |
| 2025-04-21 Option Award | 2025-04-23 5:49 pm | N/A 2030-04-21 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 3,223,728 | $0 | 3,223,728 (Indirect) | View |
| 2025-04-14 Option Award | 2025-04-18 5:28 pm | N/A 2035-04-14 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) *Director by Deputization Director | 17,600 | $0 | 17,600 (Indirect) | View |
| 2025-02-27 Exercise | 2025-03-03 7:02 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 353,249 | $0.9306 | 4,575,556 (Indirect) | View |
| 2025-02-27 Exercise | 2025-03-03 7:02 pm | 2024-07-09 2026-07-09 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 3,223,726 | $0 | 4,575,556 (Indirect) | View |
| 2025-02-27 Option Award | 2025-03-03 7:02 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 2,517,228 | $0 | 4,575,556 (Indirect) | View |
| 2024-09-17 Conversion | 2024-09-17 6:16 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner | 16,809,237 | $0 | 897,587 (Indirect) | View |
Ownership | 2024-09-12 9:07 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,725,174 (Indirect) | View |
| 2024-07-15 Exercise | 2024-07-17 6:09 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 5,894,766 | $0 | 9,033,963 (Indirect) | View |
| 2024-07-11 Option Award | 2024-07-15 7:19 pm | N/A 2034-07-11 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) *Director by Deputization Director | 264,000 | $0 | 264,000 (Indirect) | View |
| 2024-07-09 Option Award | 2024-07-11 6:47 pm | N/A 2027-01-28 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner | 41,794,350 | $0 | 41,794,350 (Indirect) | View |
| 2024-06-12 Option Award | 2024-06-14 5:05 pm | N/A 2034-06-12 | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 10,077 | $0 | 20,001,101 (Indirect) | View |
| 2024-05-29 Option Award | 2024-06-03 6:31 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 19,000 | $0 | 19,000 (Indirect) | View |
| 2024-03-15 Option Award | 2024-03-19 9:39 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner | 3,162,729 | $0 | 3,189,709 (Indirect) | View |
Ownership | 2024-03-08 5:43 pm | N/A N/A | AdaptHealth Corp. | AHCO | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 27,654,923 (Indirect) | View |
| 2024-02-06 Conversion | 2024-02-08 2:07 pm | N/A N/A | Fractyl Health Inc. | GUTS | Flynn James E Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Possible Members of 10% Group 10% Owner | 2,624,565 | $0 | 834,254 (Indirect) | View |
Ownership | 2024-02-01 6:55 pm | N/A N/A | Fractyl Health Inc. | GUTS | Flynn James E Deerfield Private Design Fund III L.P. Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Possible Member of 10% Group 10% Owner | 0 | $0 | 834,254 (Indirect) | View |
| 2023-11-17 Exercise | 2023-11-21 6:09 pm | N/A N/A | CareMax Inc. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 12,123 | $0 | 15,823,213 (Indirect) | View |
| 2023-07-28 Other | 2023-08-01 5:24 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Flynn James E Director by Deputization Director 10% Owner | 1,600,000 | $0 | 2,250,000 (Indirect) | View |
| 2022-06-16 Option Award | 2023-06-20 8:10 pm | N/A 2032-06-16 | Acutus Medical Inc. | AFIB | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by deputization Director | 56,000 | $0 | 6,924,305 (Indirect) | View |
| 2023-06-15 Option Award | 2023-06-16 6:46 pm | N/A 2033-06-15 | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by deputization Director 10% Owner | 30,000 | $0 | 30,000 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-12 8:18 pm | N/A N/A | CareMax Inc. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 33,750 | $0 | 33,750 (Indirect) | View |
| 2023-05-09 Option Award | 2023-05-11 6:31 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 8,300 | $0 | 8,300 (Indirect) | View |
| 2022-11-17 Option Award | 2022-11-21 7:31 pm | N/A N/A | CareMax Inc. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 12,123 | $0 | 12,123 (Indirect) | View |
Ownership | 2022-11-14 6:12 pm | N/A N/A | Frazier Lifesciences Acquisition Corp | FLAC | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 0 | $0 | 2,572,986 (Indirect) | View |